Third Harmonic Bio Inc

NEW
NAS:THRD (USA)  
$ 3.44 -0.020 (-0.58%) 07:08 PM EST
At Loss
P/B:
0.52
Market Cap:
$ 155.00M
Enterprise V:
$ -137.24M
Volume:
553.74K
Avg Vol (2M):
752.55K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
553.74K
At Loss
Avg Vol (2M):
752.55K

Business Description

Description
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
Name Current Vs Industry Vs History
Cash-To-Debt 87.01
Equity-to-Asset 0.97
Debt-to-Equity 0.01
Debt-to-EBITDA -0.06
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -37.8
3-Year EPS without NRI Growth Rate -30.9
3-Year FCF Growth Rate -14.1

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 35.38
9-Day RSI 33.38
14-Day RSI 29.85
3-1 Month Momentum % -68.03
6-1 Month Momentum % -73.47
12-1 Month Momentum % -60.53

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 42.5
Quick Ratio 42.5
Cash Ratio 41.91

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.9
Shareholder Yield % 0.4

Financials (Next Earnings Date:2025-03-26 Est.)

THRD's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:THRD

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Third Harmonic Bio Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.96
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % 71.39
14-Day RSI 29.85
14-Day ATR ($) 0.251522
20-Day SMA ($) 3.5
12-1 Month Momentum % -60.53
52-Week Range ($) 3.18 - 16.94
Shares Outstanding (Mil) 45.06

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Third Harmonic Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Third Harmonic Bio Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Third Harmonic Bio Inc Frequently Asked Questions

What is Third Harmonic Bio Inc(THRD)'s stock price today?
The current price of THRD is $3.44. The 52 week high of THRD is $16.94 and 52 week low is $3.18.
When is next earnings date of Third Harmonic Bio Inc(THRD)?
The next earnings date of Third Harmonic Bio Inc(THRD) is 2025-03-26 Est..
Does Third Harmonic Bio Inc(THRD) pay dividends? If so, how much?
Third Harmonic Bio Inc(THRD) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1